GO:1900864 mitochondrial RNA modification: Metabolic Plasticity and Disease, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900864 (mitochondrial RNA modification) is defined as any RNA modification that takes place in the mitochondrion, including editing, methylation, pseudouridylation, and other covalent changes.
• Mitochondrial RNA modifications are essential for mitochondrial gene expression, including tRNA and rRNA maturation, and for shaping metabolic plasticity in cancer metastasis.
• Key modifications include 5-methylcytosine (m5C) on mitochondrial double-stranded RNA, which marks these RNAs for degradation and prevents cytosolic release.
• Pseudouridylation of mitochondrial tRNAs governs erythropoiesis, linking mitochondrial RNA modification to blood cell development.
• Dysregulation of mitochondrial RNA modification is implicated in cancer metastasis, metabolic disorders, and mitochondrial diseases, making it a novel therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of mitochondrial RNA modification enzymes and their roles in disease.
Description
Mitochondrial RNA modification (GO:1900864) encompasses all covalent chemical changes to RNA molecules that occur within the mitochondrion. This includes modifications such as methylation, pseudouridylation, and editing events that are critical for the proper function of mitochondrial RNAs, particularly tRNAs and rRNAs. These modifications are essential for mitochondrial gene expression, as they ensure the stability, folding, and translational fidelity of mitochondrial transcripts. The importance of mitochondrial RNA modification extends beyond basic mitochondrial biology; recent studies have shown that these modifications shape metabolic plasticity and influence cancer metastasis. For researchers, understanding GO:1900864 provides a framework to investigate how mitochondrial RNA modifications contribute to cellular metabolism, stress responses, and disease pathogenesis. The field has gained prominence with the discovery that mitochondrial RNA modifications can be targeted for therapeutic intervention, particularly in cancer and metabolic disorders.
mitochondrial RNA modification At A Glance
| GO ID | GO:1900864 |
|---|---|
| GO term | mitochondrial RNA modification |
| Ontology | biological_process |
| Synonym | mitochondrial RNA editing |
| Major function | Covalent modification of mitochondrial RNAs, including methylation, pseudouridylation, and editing, to regulate mitochondrial gene expression and metabolism |
| Related processes | Mitochondrial RNA maturation, tRNA modification, rRNA modification, double-stranded RNA degradation |
| Cellular location | Mitochondrion (mitochondrial matrix and inner membrane) |
| Key enzymes | Methyltransferases, pseudouridine synthases, editing enzymes |
| Disease relevance | Cancer metastasis, erythropoiesis disorders, metabolic diseases |
What Is GO:1900864?
GO:1900864, mitochondrial RNA modification, is a biological process defined as any RNA modification that takes place in the mitochondrion. This includes enzymatic and non-enzymatic covalent alterations to mitochondrial RNA molecules, such as methylation, pseudouridylation, and editing, which affect RNA stability, structure, and function. The term is synonymous with mitochondrial RNA editing, though it encompasses a broader range of modifications beyond editing.
Why Is mitochondrial RNA modification Important in Cell Biology?
Mitochondrial RNA modification is critical for maintaining mitochondrial function and cellular homeostasis. Modifications such as m5C on mitochondrial double-stranded RNA mark these molecules for degradation, preventing their accumulation and cytosolic release, which could trigger innate immune responses. Dysregulation of these modifications has been linked to metabolic reprogramming in cancer cells, promoting metastasis. Furthermore, pseudouridylation of mitochondrial tRNAs is essential for erythropoiesis, and its disruption leads to impaired red blood cell development. Thus, understanding GO:1900864 offers insights into fundamental mitochondrial biology and provides potential therapeutic targets for cancer, metabolic disorders, and mitochondrial diseases.
• Regulates mitochondrial gene expression by ensuring proper folding and stability of mitochondrial tRNAs and rRNAs.
• Controls metabolic plasticity in cancer cells, influencing metastasis and tumor progression.
• Prevents aberrant immune activation by degrading mitochondrial double-stranded RNA through m5C modification.
• Essential for erythropoiesis via pseudouridylation of mitochondrial tRNAs.
• Represents a novel therapeutic target for combating cancer metastasis.
• Enables RNA interference therapeutics through targeted mitochondrial RNA modification.
• Links cellular metabolism to RNA modifications, with implications for metabolism-targeted therapy.
• Provides a mechanism for mitochondrial quality control and stress responses.
• Involved in the evolutionary origin of RNA modification as a suppressor of Toll-like receptor recognition.
• Offers potential biomarkers for mitochondrial diseases and metabolic disorders.
What Happens During mitochondrial RNA modification?
Recognition and Targeting of Mitochondrial RNAs
In simple terms: Enzymes find specific mitochondrial RNAs and prepare them for modification.
Mitochondrial RNA modification begins with the recognition of target RNAs by modification enzymes. These enzymes, such as methyltransferases and pseudouridine synthases, specifically bind to mitochondrial transcripts, often guided by sequence motifs or structural features. For example, the m5C methyltransferase NSUN2 recognizes mitochondrial double-stranded RNA and adds a methyl group to cytosine residues. This targeting ensures that modifications occur at precise locations, which is crucial for their functional impact on RNA stability and translation.
Catalytic Addition of Chemical Modifications
In simple terms: Chemical groups are added to RNA bases, changing their properties.
Once bound, modification enzymes catalyze the covalent addition of chemical groups to RNA bases. Common modifications include methylation (e.g., m5C, m6A), pseudouridylation (conversion of uridine to pseudouridine), and editing (e.g., C-to-U or A-to-I changes). These modifications alter the base-pairing properties and structural stability of the RNA. For instance, pseudouridylation enhances tRNA rigidity and translational fidelity. The m5C modification on mitochondrial double-stranded RNA serves as a mark for degradation, preventing the accumulation of immunogenic RNA.
Functional Consequences for Mitochondrial Gene Expression
In simple terms: Modified RNAs work better or are degraded, affecting mitochondrial protein production.
The added modifications have diverse functional consequences. Methylation and pseudouridylation of mitochondrial tRNAs improve their folding and interaction with the ribosome, enhancing mitochondrial translation. In contrast, m5C modification of mitochondrial double-stranded RNA leads to its degradation, thereby preventing cytosolic release and innate immune activation. These modifications collectively ensure proper mitochondrial gene expression and cellular metabolism.
Regulation and Dynamics of Mitochondrial RNA Modifications
In simple terms: The amount and types of modifications can change based on cell needs.
Mitochondrial RNA modifications are dynamic and can be regulated in response to cellular signals. For example, metabolic stress can alter the expression or activity of modification enzymes, leading to changes in modification patterns. This plasticity allows cells to adapt mitochondrial function to changing metabolic demands, such as during cancer metastasis. The interplay between modification enzymes and their targets is subject to regulation by signaling pathways, though the exact mechanisms are still being elucidated.
Role in Cellular Metabolism and Disease
In simple terms: These modifications help cells adjust their energy production and can go wrong in diseases.
Mitochondrial RNA modifications are integral to metabolic reprogramming. In cancer, altered modifications support the metabolic plasticity required for metastasis. Targeting these modifications has emerged as a therapeutic strategy, with studies showing that interfering with mitochondrial RNA modification can inhibit cancer progression. Additionally, defects in pseudouridylation impair erythropoiesis, highlighting the importance of these modifications in normal physiology.
Key Genes Involved in GO:1900864 mitochondrial RNA modification
The following genes encode enzymes and factors involved in mitochondrial RNA modification, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NSUN2 | m5C methyltransferase that modifies mitochondrial double-stranded RNA | Regulates degradation of mitochondrial dsRNA and prevents cytosolic release |
| PUS1 | Pseudouridine synthase that modifies mitochondrial tRNAs | Essential for erythropoiesis; mutations linked to mitochondrial myopathy |
| TRUB2 | Pseudouridine synthase involved in mitochondrial tRNA modification | Potential role in mitochondrial translation and disease |
| MTO1 | Mitochondrial tRNA modification enzyme | Associated with mitochondrial cardiomyopathy |
| GTPBP3 | Mitochondrial tRNA modification enzyme | Defects cause mitochondrial encephalomyopathy |
| ELAC2 | Mitochondrial tRNA 3' processing and modification | Linked to mitochondrial disease and cancer |
| PNPT1 | Mitochondrial RNA import and degradation | Involved in mitochondrial RNA quality control |
| SUPV3L1 | Mitochondrial RNA helicase and modification | Affects mitochondrial RNA stability |
| LRPPRC | Mitochondrial mRNA stability and modification | Mutations cause Leigh syndrome |
| SLIRP | Mitochondrial RNA-binding protein | Regulates mitochondrial mRNA stability |
| METTL15 | Mitochondrial rRNA methyltransferase | Required for mitochondrial ribosome assembly |
| NSUN3 | Mitochondrial tRNA m5C methyltransferase | Modifies mitochondrial tRNA and affects translation |
| ALKBH1 | Mitochondrial tRNA demethylase | Regulates mitochondrial translation |
| FTSJ2 | Mitochondrial rRNA methyltransferase | Involved in mitochondrial ribosome function |
| RPUSD4 | Mitochondrial RNA pseudouridine synthase | Modifies mitochondrial rRNA |
| TRMT61B | Mitochondrial tRNA methyltransferase | Affects mitochondrial translation |
| TRMT10C | Mitochondrial tRNA methyltransferase | Component of mitochondrial RNase P |
| MTPAP | Mitochondrial poly(A) polymerase | Adds poly(A) tails to mitochondrial mRNAs |
How Is mitochondrial RNA modification Regulated?
Mitochondrial RNA modification is regulated at multiple levels. The expression and activity of modification enzymes can be influenced by cellular metabolic status, stress signals, and signaling pathways such as mTOR and the integrated stress response. For instance, metabolic stress can alter the expression of NSUN2, affecting m5C levels on mitochondrial double-stranded RNA and thereby influencing their degradation. Additionally, pseudouridylation of mitochondrial tRNAs is dynamically regulated during erythropoiesis, ensuring proper translation. The interplay between modification enzymes and mitochondrial RNA targets is subject to regulation by RNA-binding proteins and post-translational modifications, though the precise mechanisms remain an active area of research.
mitochondrial RNA modification and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NSUN2 | Cancer metastasis, innate immunity | Knockout and overexpression in cancer cell lines |
| PUS1 | Erythropoiesis disorders, mitochondrial myopathy | Point mutation knock-in in hematopoietic stem cells |
| MTO1 | Mitochondrial cardiomyopathy | Knockout in cardiomyocytes |
| GTPBP3 | Mitochondrial encephalomyopathy | Knock-in of patient mutations in neurons |
| ELAC2 | Mitochondrial disease, cancer | Knockout in fibroblasts and cancer cells |
Mitochondrial RNA Modification in Cancer Metastasis
Alterations in mitochondrial RNA modifications contribute to metabolic plasticity in cancer cells, facilitating metastasis. Delaunay et al. (2022) demonstrated that mitochondrial RNA modifications shape metabolic plasticity in metastasis, suggesting that targeting these modifications could inhibit cancer spread. Huang et al. (2024) further highlighted mitochondrial RNA modification as a novel therapeutic target to combat metastasis. These findings underscore the potential of modulating mitochondrial RNA modifications for cancer therapy.
Role in Erythropoiesis and Blood Disorders
Pseudouridylation of mitochondrial tRNAs is essential for erythropoiesis. Wang et al. (2024) showed that mitochondrial tRNA pseudouridylation governs erythropoiesis, and its disruption leads to impaired red blood cell development. This links mitochondrial RNA modification to blood disorders and provides a basis for exploring therapeutic interventions in anemias and other erythropoietic defects.
Mitochondrial RNA Modification and Innate Immunity
Mitochondrial double-stranded RNA can trigger innate immune responses if released into the cytosol. Kim et al. (2024) discovered that m5C modification marks mitochondrial double-stranded RNAs for degradation, preventing their cytosolic release and immune activation. This mechanism highlights the importance of mitochondrial RNA modifications in maintaining immune homeostasis and suggests that defects in these modifications could contribute to autoimmune or inflammatory conditions.
Therapeutic Targeting of Mitochondrial RNA Modification
Mitochondrial RNA modification has emerged as a druggable process. Feng et al. (2023) developed a near-infrared light-mediated approach to modify mitochondrial RNA for cancer RNA interference therapeutics, demonstrating the potential of targeting these modifications. Additionally, Liu et al. (2024) discussed the implications of RNA modifications in cellular metabolism for metabolism-targeted therapy and immunotherapy. These studies pave the way for novel therapeutic strategies exploiting mitochondrial RNA modification.
From mitochondrial RNA modification-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NSUN2-mediated m5C modification regulate mitochondrial dsRNA degradation? | NSUN2 knockout and point mutation (catalytic dead) cell lines |
| How does PUS1 pseudouridylation affect erythropoiesis? | PUS1 knockout and knock-in of patient mutations in erythroid cells |
| Can targeting mitochondrial RNA modification inhibit metastasis? | Overexpression of modification enzymes in metastatic cancer models |
| What is the role of mitochondrial tRNA modifications in translation? | Tagged knock-in of modification enzymes for proteomics |
| Does m5C modification prevent cytosolic release of mitochondrial dsRNA? | Knockout of NSUN2 followed by RNA-seq and imaging |
| Can light-mediated mitochondrial RNA modification enhance RNAi? | Overexpression of modification enzymes with light-responsive elements |
How to Study the mitochondrial RNA modification Process
| Method | What It Measures | Typical Application |
|---|---|---|
| m5C RNA immunoprecipitation (MeRIP) | Enrichment of m5C-modified RNAs | Mapping m5C sites on mitochondrial dsRNA |
| Pseudouridine sequencing (Ψ-seq) | Pseudouridine sites in RNA | Identifying pseudouridylation of mitochondrial tRNAs |
| Mitochondrial translation assay | Rate of mitochondrial protein synthesis | Assessing impact of tRNA modifications |
| Metabolic flux analysis | Glycolysis and oxidative phosphorylation | Linking RNA modifications to metabolic plasticity |
| Proteomics (mass spectrometry) | Protein expression and interactions | Identifying modification enzyme complexes |
| RNA FISH | Localization of specific RNAs | Visualizing mitochondrial dsRNA release |
| CRISPR knockout screening | Gene function in modification pathways | Identifying novel regulators of mitochondrial RNA modification |
| Light-mediated RNA modification | Targeted modification of mitochondrial RNA | Therapeutic RNA interference |
RNA Sequencing and Modification Mapping
RNA sequencing (RNA-seq) and specialized modification mapping techniques (e.g., m5C RNA immunoprecipitation, pseudouridine sequencing) are used to identify and quantify mitochondrial RNA modifications. These methods allow researchers to determine the sites and abundance of modifications under different conditions. For example, m5C-seq can map m5C sites on mitochondrial double-stranded RNA, revealing their role in degradation.
Proteomics and Enzyme Interactomics
Proteomic approaches, including mass spectrometry and affinity purification, identify the enzymes and cofactors involved in mitochondrial RNA modification. Interactome studies can reveal how modification enzymes are recruited to their targets and how they are regulated. Tagged knock-in of modification enzymes followed by immunoprecipitation can uncover novel interacting partners.
Functional Assays for Mitochondrial Translation and Metabolism
Functional assays such as mitochondrial translation assays (e.g., puromycin incorporation) and metabolic flux analysis measure the impact of RNA modifications on mitochondrial function. These assays help link specific modifications to changes in oxidative phosphorylation and metabolic plasticity. For instance, pseudouridylation defects can be assessed by measuring mitochondrial protein synthesis and oxygen consumption.
Imaging and Live-Cell Tracking
Advanced imaging techniques, including fluorescence in situ hybridization (FISH) and live-cell RNA labeling, visualize mitochondrial RNA modifications and their dynamics. These methods can track the localization and degradation of modified RNAs, such as m5C-marked mitochondrial double-stranded RNA. Light-mediated modification approaches can also be monitored using imaging.
How CRISPR Can Be Used to Study GO:1900864 mitochondrial RNA modification
Knockout
CRISPR knockout (KO) of genes encoding mitochondrial RNA modification enzymes, such as NSUN2 or PUS1, allows researchers to study loss-of-function phenotypes. For example, NSUN2 KO leads to accumulation of mitochondrial double-stranded RNA and cytosolic release, activating innate immune responses. PUS1 KO impairs erythropoiesis, demonstrating the essential role of pseudouridylation. These models are invaluable for dissecting the physiological consequences of specific modifications.
Point Mutation
Point mutations can be introduced into catalytic residues of modification enzymes to separate their modification activity from other functions. For instance, a catalytically dead NSUN2 mutant can be knocked in to determine whether m5C modification is required for mitochondrial dsRNA degradation. Such models help distinguish between enzymatic and non-enzymatic roles of these proteins.
Knock-in
Knock-in of patient-derived mutations or tagged versions of modification enzymes enables precise modeling of disease-associated variants. For example, knocking in PUS1 mutations found in mitochondrial myopathy patients can recapitulate the disease phenotype in cell models. Tagged knock-in (e.g., FLAG or GFP) facilitates proteomic and imaging studies to track enzyme localization and interactions.
Overexpression
Overexpression of mitochondrial RNA modification enzymes can enhance specific modifications and reveal their downstream effects. Overexpressing NSUN2 increases m5C levels on mitochondrial dsRNA, promoting its degradation and reducing immune activation. In cancer models, overexpression of modification enzymes can drive metabolic plasticity and metastasis, providing a platform for testing therapeutic interventions.
How EDITGENE Supports mitochondrial RNA modification Research
Researchers studying mitochondrial RNA modification-related genes often need to determine whether a candidate gene is causally involved in the modification process, how specific mutations affect enzyme activity, and whether targeting these pathways can reverse disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to address these questions, from generating knockout and knock-in cell models to high-throughput library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial RNA modification research.
Frequently Asked Questions About mitochondrial RNA modification
What is mitochondrial RNA modification (GO:1900864)?
Mitochondrial RNA modification (GO:1900864) is any covalent chemical change to RNA molecules that occurs within the mitochondrion, including methylation, pseudouridylation, and editing. These modifications regulate mitochondrial gene expression and cellular metabolism.
What genes are involved in mitochondrial RNA modification?
Key genes include NSUN2 (m5C methyltransferase), PUS1 (pseudouridine synthase), MTO1, GTPBP3, ELAC2, and METTL15, among others. These enzymes catalyze specific modifications on mitochondrial tRNAs, rRNAs, and mRNAs.
How does mitochondrial RNA modification affect cancer?
Mitochondrial RNA modifications shape metabolic plasticity in cancer cells, promoting metastasis. Targeting these modifications, such as inhibiting NSUN2, can reduce metastatic potential and is being explored as a therapeutic strategy.
What is the role of m5C in mitochondrial RNA?
m5C (5-methylcytosine) on mitochondrial double-stranded RNA marks these RNAs for degradation, preventing their accumulation and cytosolic release. This modification is essential for avoiding innate immune activation.
Can mitochondrial RNA modification be targeted therapeutically?
Yes, recent studies have shown that targeting mitochondrial RNA modification, for example with light-mediated approaches or small molecules, can inhibit cancer progression and enhance RNA interference therapeutics.
What diseases are linked to mitochondrial RNA modification defects?
Defects in mitochondrial RNA modification are linked to cancer metastasis, erythropoiesis disorders, mitochondrial myopathy, cardiomyopathy, and encephalomyopathy.
How is mitochondrial RNA modification studied?
Common methods include RNA-seq, m5C-seq, Ψ-seq, mitochondrial translation assays, proteomics, and imaging. CRISPR knockout and knock-in models are used to dissect gene function.
What is pseudouridylation in mitochondria?
Pseudouridylation is the conversion of uridine to pseudouridine in RNA. In mitochondria, it occurs on tRNAs and is essential for translation and erythropoiesis.
Which enzyme adds m5C to mitochondrial RNA?
NSUN2 is a primary m5C methyltransferase that modifies mitochondrial double-stranded RNA, marking it for degradation.
How can CRISPR help study mitochondrial RNA modification?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to manipulate genes involved in mitochondrial RNA modification and study their effects on mitochondrial function, metabolism, and disease.
Conclusion
Mitochondrial RNA modification (GO:1900864) is a fundamental biological process that regulates mitochondrial gene expression and cellular metabolism. Its dysregulation contributes to cancer metastasis, blood disorders, and mitochondrial diseases, making it a promising therapeutic target. Advances in CRISPR-based models and RNA modification mapping are accelerating our understanding of this process. EDITGENE offers comprehensive services to support research in this field, from custom cell models to bioinformatics analysis.
References
- 1. Karikó K et al.. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.. Immunity 23(2):165-75 PMID: 16111635
- 2. Delaunay S et al.. 2022. Mitochondrial RNA modifications shape metabolic plasticity in metastasis.. Nature 607(7919):593-603 PMID: 35768510
- 3. Chrzanowska-Lightowlers ZM et al.. 2024. Mitochondrial RNA maturation.. RNA Biol 21(1):28-39 PMID: 39385590
- 4. Kim S et al.. 2024. RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release.. Mol Cell 84(15):2935-2948.e7 PMID: 39019044
- 5. Huang S et al.. 2024. Mitochondrial RNA modification: A novel therapeutic target to combat metastasis.. Cell Biol Int 48(3):233-236 PMID: 38225665
- 6. Feng Y et al.. 2023. NIR Light-Mediated Mitochondrial RNA Modification for Cancer RNA Interference Therapeutics.. Angew Chem Int Ed Engl 62(19):e202218969 PMID: 36912594
- 7. Liu WW et al.. 2024. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy.. Signal Transduct Target Ther 9(1):70 PMID: 38531882
- 8. Wang B et al.. 2024. Mitochondrial tRNA pseudouridylation governs erythropoiesis.. Blood 144(6):657-671 PMID: 38635773
